Prolysis
Oxford
About Prolysis
Prolysis is an antibacterial drug discovery and development company based in Oxford, UK. We are focused on creating new antibacterial drugs that are urgently needed to treat hospital-acquired and community-associated infections.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $6.8M
- Funding stage: Seed
- Last round: Grant (Jan 2007)
- Website: prolysis.co.uk
- Phone: +44 (0) 1865 854700
Industries & Categories
Bioinformatics, Pharmaceutical
Canonical: https://fsome.com/organization/prolysis-557796 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.